July 9, 1999 |
A Lake Forest developer and manufacturer of drug testing products scrapped plans for its initial public offering of 2.5 million common shares of stock, dashing hopes of raising up to $25 million. "We are withdrawing the IPO because of market conditions," Ansys Diagnostics Inc. chief financial officer Suzanne David said Thursday. She declined to elaborate. Ansys notified the Securities and Exchange Commission in a letter July 2 that it was calling off plans for the stock offering.
November 15, 2000 |
Ansys Diagnostics execs decided they needed a fresh corporate identity. The Lake Forest company had acquired another firm, pushing beyond its origins as a maker of diagnostic products. A name change was clearly in order. A chance for a new start. The opportunity to overhaul the company's image. Thousands of dollars for new logos, signage, stationery, business cards. Late last month, the company announced its new moniker. Ansys Diagnostics became Ansys Technologies Inc.